Datasetdouble_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls
#double_gel_24h_versus_single_gel_24h.class.cls
#double_gel_24h_versus_single_gel_24h_repos
Phenotypeclass.cls#double_gel_24h_versus_single_gel_24h_repos
Upregulated in classsingle_gel_24h
GeneSetLEADING_EDGE
Enrichment Score (ES)-0.48505688
Normalized Enrichment Score (NES)-1.5009053
Nominal p-value0.043209877
FDR q-value0.27279174
FWER p-Value1.0
Table: GSEA Results Summary



Fig 1: Enrichment plot: LEADING_EDGE   
Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List

PROBEGENE SYMBOLGENE_TITLERANK IN GENE LISTRANK METRIC SCORERUNNING ESCORE ENRICHMENT
1EVLEVL
Entrez,  Source
Enah/Vasp-like12140.083-0.0365No
2ABI3ABI3
Entrez,  Source
ABI gene family, member 325840.050-0.1064No
3PIB5PAPIB5PA
Entrez,  Source
phosphatidylinositol (4,5) bisphosphate 5-phosphatase, A30720.042-0.1154No
4APBB1APBB1
Entrez,  Source
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)34420.036-0.1194No
5FAPFAP
Entrez,  Source
fibroblast activation protein, alpha38010.031-0.1258No
6FGD4FGD4
Entrez,  Source
FYVE, RhoGEF and PH domain containing 442270.026-0.1409No
7ARFIP2ARFIP2
Entrez,  Source
ADP-ribosylation factor interacting protein 2 (arfaptin 2)42560.025-0.1265No
8WASF2WASF2
Entrez,  Source
WAS protein family, member 244330.023-0.1247No
9PDPNPDPN
Entrez,  Source
podoplanin56030.009-0.2065No
10ARF6ARF6
Entrez,  Source
ADP-ribosylation factor 66594-0.002-0.2796No
11S100BS100B
Entrez,  Source
S100 calcium binding protein B6931-0.005-0.3017No
12ABI1ABI1
Entrez,  Source
abl-interactor 17128-0.007-0.3119No
13CXCR4CXCR4
Entrez,  Source
chemokine (C-X-C motif) receptor 47175-0.007-0.3105No
14FGD1FGD1
Entrez,  Source
FYVE, RhoGEF and PH domain containing 1 (faciogenital dysplasia)7404-0.010-0.3214No
15CDC42BPACDC42BPA
Entrez,  Source
CDC42 binding protein kinase alpha (DMPK-like)7499-0.010-0.3215No
16ALS2ALS2
Entrez,  Source
amyotrophic lateral sclerosis 2 (juvenile)7724-0.013-0.3299No
17NME2NME2
Entrez,  Source
non-metastatic cells 2, protein (NM23B) expressed in8212-0.018-0.3548No
18TSC1TSC1
Entrez,  Source
tuberous sclerosis 18579-0.022-0.3681No
19CDC42BPBCDC42BPB
Entrez,  Source
CDC42 binding protein kinase beta (DMPK-like)8784-0.024-0.3678No
20TLN1TLN1
Entrez,  Source
talin 19094-0.027-0.3733No
21CDK6CDK6
Entrez,  Source
cyclin-dependent kinase 69381-0.030-0.3751No
22CTTNCTTN
Entrez,  Source
cortactin9710-0.034-0.3773No
23MYH9MYH9
Entrez,  Source
myosin, heavy chain 9, non-muscle10920-0.050-0.4352Yes
24ITGB1ITGB1
Entrez,  Source
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)11016-0.051-0.4086Yes
25DBNLDBNL
Entrez,  Source
drebrin-like11131-0.054-0.3820Yes
26MYO5AMYO5A
Entrez,  Source
myosin VA (heavy chain 12, myoxin)12504-0.092-0.4248Yes
27BCAR1BCAR1
Entrez,  Source
breast cancer anti-estrogen resistance 112923-0.123-0.3750Yes
28S100A11S100A11
Entrez,  Source
S100 calcium binding protein A1113140-0.159-0.2865Yes
29S100A6S100A6
Entrez,  Source
S100 calcium binding protein A613330-0.4580.0009Yes
Table: GSEA details [plain text format]



Fig 2: LEADING_EDGE   
Blue-Pink O' Gram in the Space of the Analyzed GeneSet



Fig 3: LEADING_EDGE: Random ES distribution   
Gene set null distribution of ES for LEADING_EDGE